117 related articles for article (PubMed ID: 37619682)
1. Micro array patch assisted transdermal delivery of high dose, ibuprofen sodium using thermoresponsive sodium alginate/poly (vinylcaprolactam) in situ gels depot.
Khan S; Minhas MU
Int J Biol Macromol; 2023 Dec; 252():126464. PubMed ID: 37619682
[TBL] [Abstract][Full Text] [Related]
2. Microneedles assisted controlled and improved transdermal delivery of high molecular drugs via
Khan S; Minhas MU; Singh Thakur RR; Aqeel MT
Drug Dev Ind Pharm; 2022 Jun; 48(6):265-278. PubMed ID: 35899871
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of microneedles-assisted in situ depot forming poloxamer gels for sustained transdermal drug delivery.
Khan S; Minhas MU; Tekko IA; Donnelly RF; Thakur RRS
Drug Deliv Transl Res; 2019 Aug; 9(4):764-782. PubMed ID: 30675693
[TBL] [Abstract][Full Text] [Related]
4. Poly (vinyl alcohol) microneedles: Fabrication, characterization, and application for transdermal drug delivery of doxorubicin.
Nguyen HX; Bozorg BD; Kim Y; Wieber A; Birk G; Lubda D; Banga AK
Eur J Pharm Biopharm; 2018 Aug; 129():88-103. PubMed ID: 29800617
[TBL] [Abstract][Full Text] [Related]
5. Elucidating the Impact of Surfactants on the Performance of Dissolving Microneedle Array Patches.
Anjani QK; Sabri AHB; Utomo E; Domínguez-Robles J; Donnelly RF
Mol Pharm; 2022 Apr; 19(4):1191-1208. PubMed ID: 35235330
[TBL] [Abstract][Full Text] [Related]
6. Sodium alginate/N-(Vinylcaprolactam) based supramolecular self-assembled subcutaneously administered in situ formed gels depot of 5-fluorouracil: Rheological analysis, in vitro cytotoxic potential, in vivo bioavailability and safety evaluation.
Khan S; Minhas MU; Akhtar N; Thakur RRS
Int J Biol Macromol; 2022 Jun; 211():425-440. PubMed ID: 35577197
[TBL] [Abstract][Full Text] [Related]
7. Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin.
Yu W; Jiang G; Zhang Y; Liu D; Xu B; Zhou J
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():187-196. PubMed ID: 28866156
[TBL] [Abstract][Full Text] [Related]
8. Role of sodium l-cysteine alginate conjugate and isopropyl myristate to enhance the permeation enhancing activity of BCS class III drug from TDDS; optimization by central composite design and
Sadashivaiah R; Babu BKS
Drug Dev Ind Pharm; 2020 Sep; 46(9):1427-1442. PubMed ID: 32623912
[TBL] [Abstract][Full Text] [Related]
9. Quality by design approach to prepare oleoyl alginate derivative and its use in transdermal delivery.
Al-Remawi M; Hamam F; Hamaidi M
Pharm Dev Technol; 2015 Mar; 20(2):227-36. PubMed ID: 24266691
[TBL] [Abstract][Full Text] [Related]
10. Fabrication and mechanical modelling of dissolvable PVA/PVP composite microneedles with biocompatibility for efficient transdermal delivery of ibuprofen.
Xiao M; Wang Z; An Y; Dai Y; Wang X; Zhu Z
J Biomater Sci Polym Ed; 2024 Jun; 35(9):1439-1454. PubMed ID: 38590076
[TBL] [Abstract][Full Text] [Related]
11. Fabrication and characterisation of self-applicating heparin sodium microneedle patches.
Arshad MS; Zafar S; Zahra AT; Zaman MH; Akhtar A; Kucuk I; Farhan M; Chang MW; Ahmad Z
J Drug Target; 2021 Jan; 29(1):60-68. PubMed ID: 32649227
[TBL] [Abstract][Full Text] [Related]
12. Sodium alginate microneedle arrays mediate the transdermal delivery of bovine serum albumin.
Demir YK; Akan Z; Kerimoglu O
PLoS One; 2013; 8(5):e63819. PubMed ID: 23675508
[TBL] [Abstract][Full Text] [Related]
13. Fabrication, characterization and application of sugar microneedles for transdermal drug delivery.
Nguyen HX; Banga AK
Ther Deliv; 2017 Mar; 8(5):249-264. PubMed ID: 28361607
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsion-based dissolving microneedle arrays for enhanced intradermal and transdermal delivery.
Nasiri MI; Vora LK; Ershaid JA; Peng K; Tekko IA; Donnelly RF
Drug Deliv Transl Res; 2022 Apr; 12(4):881-896. PubMed ID: 34939170
[TBL] [Abstract][Full Text] [Related]
15. Design of antihistaminic transdermal films based on alginate-chitosan polyelectrolyte complexes: characterization and permeation studies.
Lefnaoui S; Moulai-Mostefa N; Yahoum MM; Gasmi SN
Drug Dev Ind Pharm; 2018 Mar; 44(3):432-443. PubMed ID: 29098871
[TBL] [Abstract][Full Text] [Related]
16. Hydrogel-forming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery.
Donnelly RF; McCrudden MT; Zaid Alkilani A; Larrañeta E; McAlister E; Courtenay AJ; Kearney MC; Singh TR; McCarthy HO; Kett VL; Caffarel-Salvador E; Al-Zahrani S; Woolfson AD
PLoS One; 2014; 9(10):e111547. PubMed ID: 25360806
[TBL] [Abstract][Full Text] [Related]
17. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique.
Donnelly RF; Majithiya R; Singh TR; Morrow DI; Garland MJ; Demir YK; Migalska K; Ryan E; Gillen D; Scott CJ; Woolfson AD
Pharm Res; 2011 Jan; 28(1):41-57. PubMed ID: 20490627
[TBL] [Abstract][Full Text] [Related]
18. Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.
McCrudden MT; Alkilani AZ; McCrudden CM; McAlister E; McCarthy HO; Woolfson AD; Donnelly RF
J Control Release; 2014 Apr; 180(100):71-80. PubMed ID: 24556420
[TBL] [Abstract][Full Text] [Related]
19. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
20. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole.
Ahmed TA; El-Say KM
Life Sci; 2014 Aug; 110(1):35-43. PubMed ID: 24997393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
